The share puts GLP-1 or dual GIP/GLP-1 use at about 6% of UK adults and roughly 11% of US adults, with restaurants adjusting what they serve.
Recap by typeshit. Post by Facebook on Facebook.
BuzzFeed notes these medications have helped people worldwide, pro athletes among them, with weight, appetite and blood sugar control.
Novo Nordisk's weight loss drug brand is the presenting sponsor of the playoff game, airing at 4:30 PM ET on TSN, RDS and CFL+.
Novo Nordisk's Wegovy puts its name on the October 31 playoff game in Canada, airing at 4:30 PM ET on TSN, RDS and CFL+.
A doctor writes about a 45-year-old woman without diabetes who came in for obesity treatment, opening a column on how such patients are handled.
FT Weekend sits down with Lotte Bjerre Knudsen, a key scientist behind GLP-1 drugs, who has a message for food makers.
A shared study finding says people on GLP-1 drugs cut their drink spending by about 30 percent when they go out.
Loading…